Search research articles
Contact Us
Filters
Showing results (451-460 of 511) with videos related to
Page
of 52
Sort By:
Journal of Neuropathology and Experimental Neurology
|
February 22, 2022
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
European Radiology
|
October 27, 2023
Positive rate and quantification of amyloid pathology with [<sup>18</sup>F]florbetapir in the urban Chinese population
Kun He, Binyin Li, Lin Huang, et al.
JAMA Neurology
|
April 20, 2013
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease
Hillary D Protas, Kewei Chen, Jessica B S Langbaum, et al.
Neurotrauma Reports
|
April 24, 2024
Brain Fluid Clearance After Traumatic Brain Injury Measured Using Dynamic Positron Emission Tomography
Tracy Butler, Julia Schubert, Nikolaos A Karakatsanis, et al.
JAMA Neurology
|
February 14, 2018
Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease
Yakeel T Quiroz, Reisa A Sperling, Daniel J Norton, et al.
Acta Neuropathologica Communications
|
November 21, 2013
Clinical and multimodal biomarker correlates of ADNI neuropathological findings
Jon B Toledo, Nigel J Cairns, Xiao Da, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2015
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region
Kewei Chen, Auttawut Roontiva, Pradeep Thiyyagura, et al.
JAMA Network Open
|
August 31, 2021
Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort
Joshua T Fox-Fuller, Arabiye Artola, Kewei Chen, et al.
Alzheimer'S Research & Therapy
|
September 21, 2018
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)
Stephen Salloway, Lee A Honigberg, William Cho, et al.
Archives of Neurology
|
April 14, 2010
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele
Jessica B S Langbaum, Kewei Chen, Richard J Caselli, et al.
Page
of 52
Search research articles
Search
Showing results (451-460 of 511) with videos related to
Sort By:
Page
of 52
Journal of Neuropathology and Experimental Neurology
|
February 22, 2022
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
European Radiology
|
October 27, 2023
Positive rate and quantification of amyloid pathology with [<sup>18</sup>F]florbetapir in the urban Chinese population
Kun He, Binyin Li, Lin Huang, et al.
JAMA Neurology
|
April 20, 2013
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease
Hillary D Protas, Kewei Chen, Jessica B S Langbaum, et al.
Neurotrauma Reports
|
April 24, 2024
Brain Fluid Clearance After Traumatic Brain Injury Measured Using Dynamic Positron Emission Tomography
Tracy Butler, Julia Schubert, Nikolaos A Karakatsanis, et al.
JAMA Neurology
|
February 14, 2018
Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease
Yakeel T Quiroz, Reisa A Sperling, Daniel J Norton, et al.
Acta Neuropathologica Communications
|
November 21, 2013
Clinical and multimodal biomarker correlates of ADNI neuropathological findings
Jon B Toledo, Nigel J Cairns, Xiao Da, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 7, 2015
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region
Kewei Chen, Auttawut Roontiva, Pradeep Thiyyagura, et al.
JAMA Network Open
|
August 31, 2021
Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort
Joshua T Fox-Fuller, Arabiye Artola, Kewei Chen, et al.
Alzheimer'S Research & Therapy
|
September 21, 2018
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)
Stephen Salloway, Lee A Honigberg, William Cho, et al.
Archives of Neurology
|
April 14, 2010
Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele
Jessica B S Langbaum, Kewei Chen, Richard J Caselli, et al.
Page
of 52